fbpx

Given there were no other organizations dedicated to raising awareness and educate on the benefits of stem cell therapy for DMD and other rare diseases. This is our why and we continue to realize the dire need for our role to enhance advocacy and education to help more families we relate to.

Our Mission

Advance stem cell therapy to become the Standard of Care for Duchenne and other rare, chronic and incurable diseases, while becoming the go-to resource for people seeking therapy.

Our Vision

Provide a renewed hope for people with Muscular Dystrophy and other life-threatening diseases by advancing support, education, and access to adult stem cell therapy.

  • Todd Wiedemann

    Todd Wiedemann

    Board President

    Co-Director – Kansas MTSS and Alignment

  • Christie Benton

    Christie Benton

    Director

    CEO – Synatec Neuro, Inc.

  • Josh Nicolay

    Director

    Attorney at Law – Stull, Beverlin, Nicolay & Haas, LLC

  • Chrissy Robben Corresponding Secretary

    Chrissy Robben

    Director

    CEO – Hexcode Designs, LLC

  • Lucas Dudgeon

    Vice President/Secretary

    Strategic Account Executive – Virgin Pulse

  • Logan Woodbridge

    Treasurer

    AVP Business Banker – Sunflower Bank

  • Lacie Leatherman

    Lacie Leatherman

    Director

    Owner – LML Ventures

  • Chad Clark

    Chad Clark

    Fmr Director – Planned Giving

    Wichita State University Foundation

  • Jason Ladner

    Jason Ladner

    Business Development Executive

    Blue Cross & Blue Shield of KS

  • Dennis Mullin

    Dennis Mullin

    Fmr Chairman – KS Board of Regents &

    Chairman SPS Companies

  • Diane Heyman

    Fmr Chief People Officer

    ALSAC St Jude Children’s Research Hospital